newest glp-1 drugs A new wave of weight-loss therapies aims to be better than today's GLP-1s FDA approves Wegovy pill and

Sam Fazeli, director of research at Bloomberg Intelligence, said in a best-case scenario that the drug could only be launched in 2028, at which stage multiple competitors might be available. Outpaced by rivals Danuglipron was designed as a needle-free alternative to popular weight-loss shots from Novo Nordisk A/S and Eli Lilly & Co

Buteau, J

Classification of heart failure according to ejection fraction: JACC review topic of the week

These findings underscore albiglutides potential as an effective adjunct therapy for glycemic control and cardiovascular risk reduction in T2DM management

Glucagon-like peptide 1 (GLP-1) agonists are a class of medication used to treat type 2 diabetes

Y., Kim, S